Gikakis Nicolas 4
4 · AETHLON MEDICAL INC · Filed Apr 21, 2026
Research Summary
AI-generated summary of this filing
Aethlon Medical Director Nicolas Gikakis Receives RSU Award (21,815)
What Happened Nicolas Gikakis, a director of Aethlon Medical (AEMD), was granted 21,815 restricted stock units (RSUs) on 2026-04-17. The grant is reported at an imputed price of $2.29 per share for an aggregate value of $49,956. This is a compensation award (code A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-17
- Form 4 filed: 2026-04-21 (filed timely)
- Transaction type/code: Award/Grant (A) — RSUs
- Quantity and value: 21,815 RSUs @ $2.29 = $49,956 aggregate
- Shares owned after transaction: Not disclosed in this filing
- Footnote: RSUs vest in four equal quarterly installments on 06/30/2026, 09/30/2026, 12/31/2026 and 03/31/2027, subject to continued service.
Context RSUs are a compensation/retention vehicle; the shares are not delivered until they vest, so this is not an immediate market purchase or sale. Because the award vests over time and is contingent on continued service, it represents future potential equity rather than current trading activity. The filing contains no indication of option exercises, sales, gifts, or a 10% owner transaction.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-17$2.29/sh+21,815$49,956→ 22,844 total
Footnotes (1)
- [F1]The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.